PENNY WALLMAN: Open Payments
NPI 1346698941 · BRONSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 49 payments from 16 companies in 2025. Trend: 2023 $909 · 2024 $961 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $259 |
| GlaxoSmithKline, LLC. | 10 | $228 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Otsuka America Pharmaceutical, Inc. | 6 | $123 |
| PFIZER INC. | 1 | $119 |
| Electromed, Inc. | 4 | $47 |
| Viatris Specialty LLC | 1 | $45 |
| ABBVIE INC. | 3 | $43 |
| Amgen Inc. | 1 | $31 |
Products named: CAPLYTA, AIRSUPRA, Auvelity, REXULTI, NUCALA, NURTEC ODT, TRELEGY ELLIPTA, SMARTVEST.
Industry payments across MI — which companies pay providers there.
